Trial Profile
A study to evaluate whether tocilizumab makes negative slope of inverse-creatinine gentle and delays the time to hemodialysis induction in AA amyloidosis patients with rheumatoid arthritis of severe renal insufficiency.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate; Prednisolone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 29 Jul 2015 New trial record